It appears that someone will always risk some capital when there are prospects of a winning drug. Given the relative strength of JAV's product line (with 1 of 3 products on the market and 3 of 3 candidates likely to reach the market), I think that there will be plenty of interest in any shelf registration.
BTW, if there are hard ball playing institutions working to pick up shares on the cheap (and it appears there are such entities working here) don't you think that they are having a good laugh at their ability to shake you loose of 120K shares after you blab on this board about your dissatisfaction?
aj
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM